Evaluation of the MassTrak Immunosuppressant XE Kit for the determination of everolimus and cyclosporin A in human whole blood employing isotopically labeled internal standards
Authors:
- Sollip KimSKSollip Kim
- Hee-Jung ChungHCHee-Jung Chung
- Woochang LeeWLWoochang Lee
- Sail ChunSCSail Chun
- Won-Ki MinWMWon-Ki Min
- 1 January 2011
- journal article
- research article
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 49 (12) , 2021-7
Abstract
Liquid chromatography-tandem mass spectrometry (LC-MS/MS) is widely used for therapeutic drug monitoring of immunosuppressants given to transplant recipients. This study evaluated the performance of the newly introduced MassTrak Immunosuppressant XE Kit (Waters Corporation; “the Kit”) in the determination of everolimus and cyclosporin A (CsA) using LC-MS/MS.The linearity, precision, detection limit, carryover and matrix effect of the Kit and comparison of the in-house method and Kit procedure were evaluated according to Clinical and Laboratory Standards Institute guidelines.The Kit afforded good linearity in the measurement of everolimus from 2 to 26 ng/mL (RThe Kit employing isotopically labeled internal standards provides reliable measurements of immunosuppressant levels over a broad range of concentrations.Keywords
This publication has 23 references indexed in Scilit:
- Multi-center evaluation of a commercial Kit for tacrolimus determination by LC/MS/MSClinical Biochemistry, 2010
- Therapeutic drug monitoring of everolimus using the dried blood spot method in combination with liquid chromatography–mass spectrometryJournal of Pharmaceutical and Biomedical Analysis, 2009
- Recent development in application of high performance liquid chromatography-tandem mass spectrometry in therapeutic drug monitoring of immunosuppressantsJournal of Immunological Methods, 2008
- High-Performance Liquid Chromatography Versus Immunoassay for the Measurement of Sirolimus: Comparison of Two MethodsTransplantation Proceedings, 2006
- A rapid HPLC-mass spectrometry cyclosporin method suitable for current monitoring practicesClinical Biochemistry, 2005
- Matrix effects: the Achilles heel of quantitative high-performance liquid chromatography–electrospray–tandem mass spectrometryClinical Biochemistry, 2005
- Therapeutic drug monitoring of cyclosporineTransplantation Proceedings, 2004
- Clinical Pharmacokinetics of EverolimusClinical Pharmacokinetics, 2004
- Therapeutic Drug Monitoring of CyclosporinClinical Pharmacokinetics, 1989
- Clinical Pharmacokinetics of CyclosporinClinical Pharmacokinetics, 1986